𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Maintenance of bone mineral density of femoral cortex in ovariectomized rats after withdrawal of concurrent administration of human parathyroid hormone (1–34) and incardronate disodium (YM175)

✍ Scribed by Liu Zhang; Hideaki E. Takahashi; Tatsuhiko Tanizawa; Naoto Endo; Noriaki Yamamoto

Publisher
Springer
Year
1997
Tongue
English
Weight
693 KB
Volume
15
Category
Article
ISSN
0914-8779

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Maintaining bone mass by bisphosphonate
Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats
✍ Yuichi Takano; Tatsuhiko Tanizawa; Tasuku Mashiba; Naoto Endo; Saburo Nishida; H 📂 Article 📅 2009 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 791 KB

Intermittent treatment with human parathyroid hormone (1-34) ] stimulates bone formation and increases cancellous bone mass in ovariectomized (OW) rats. But PTH-induced cancellous bone rapidly disappears upon cessation of treatment. The fate of cortical bone treated by PTH has not been well characte

Effects of combined and separate intermi
Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1–34) and 17β-estradiol on bone histomorphometry in ovariectomized rats with established osteopenia
✍ V. Shen; D. W. Dempster; R. W. E. Mellish; R. Birchman; W. Horbert; R. Lindsay 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 819 KB

To evaluate the potential use of a combination of parathyroid hormone (PTH) and estrogen as therapy for osteoporosis, we examined the effects of combined and separate administration of low-dose PTH and estradiol in ovariectomized rats with established osteopenia. Ovariectomized rats were untreated f